The activated TSHR-induced signaling cascades, as mentioned above, have been shown to serve as oncogenic pathways in thyroid cancer, especially in tumors carrying mutations at V600E in B-Raf proto-oncogene. The gene discussed is TSHR; the disease is thyroid gland carcinoma.